Connection

JASON ERIKSEN to alpha-Synuclein

This is a "connection" page, showing publications JASON ERIKSEN has written about alpha-Synuclein.
Connection Strength

0.659
  1. 1-Indanone and 1,3-indandione Derivatives as Ligands for Misfolded a-Synuclein Aggregates. ChemMedChem. 2022 01 19; 17(2):e202100611.
    View in: PubMed
    Score: 0.190
  2. Cycad Genotoxin Methylazoxymethanol Disrupts the Brain Ubiquitin-Proteasome Pathway, Tau and a-Synuclein, as Reported in ALS-PDC. J Neuropathol Exp Neurol. 2021 02 22; 80(3):286-288.
    View in: PubMed
    Score: 0.181
  3. The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins. J Biol Chem. 2013 Jan 11; 288(2):1114-24.
    View in: PubMed
    Score: 0.102
  4. Biologic models of neurodegenerative disorders. Handb Clin Neurol. 2008; 89:173-88.
    View in: PubMed
    Score: 0.073
  5. Gene dosage and pathogenesis of Parkinson's disease. Trends Mol Med. 2005 Mar; 11(3):91-6.
    View in: PubMed
    Score: 0.060
  6. Caught in the act: alpha-synuclein is the culprit in Parkinson's disease. Neuron. 2003 Oct 30; 40(3):453-6.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.